September 12, 2023analysis, analytics, business, cannabis, cbd, compliance, consumer, cultivation, Epidiolex, europe, European, extraction, Federal, government, growing, industry, international, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, product, Quality, regulation, regulations, regulatory, retail, safety, state, test, Testing, UK, union, United Kingdom, United States

The CBD Regulatory Environment in Europe: Part 4

This is the final piece of a four-part series discussing European cannabis regulations. Click here for Part One, here for Part Two and here […]

September 6, 2023analysis, business, cannabis, cbd, compliance, consumer, cultivation, Epidiolex, EU, European, extraction, farm bill, FDA, Federal, FSA, government, growing, GW Pharma, industry, international, laboratories, laboratory, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, product, Quality, regulation, regulations, regulatory, retail, safety, state, test, Testing, thc, UK, union, United Kingdom

The CBD Regulatory Environment in Europe: Part 3

This is Part Three of a four-part series discussing European cannabis regulations. Click here for Part One and here for Part Two. Part […]

August 29, 2023american, analysis, analytics, authority, British, business, cannabis, cbd, compliance, consumer, cultivation, dispensary, EFSA, Epidiolex, europe, European, export, extraction, FDA, Federal, food, government, growing, import, industry, international, lab, laboratories, laboratory, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, product, Quality, regulation, regulations, regulatory, safety, state, thc, UK, union, United Kingdom, United States

The CBD Regulatory Environment in Europe: Part 2

This is Part Two of a four-part series discussing European cannabis regulations. Click here for Part One. Part Two analyzes the differences […]

August 23, 2023analysis, analytics, business, cannabis, cbd, consumer, dispensary, europe, European, extraction, Federal, food, government, growing, industry, international, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, novel, product, Quality, recreational, regulation, regulations, regulatory, Shelley Stark, thc, UK, union, United Kingdom

The CBD Regulatory Environment in Europe: Part 1

This is Part One of a four-part series discussing European cannabis regulations. Part One serves as an introduction. Part Two, coming next […]

January 5, 2023analysis, analytics, Bloomwell, business, Business Analysis, C-suite, CANADA, canadian, cannabis, capital, capitalist, cbd, compliance, consumer, cultivation, dispensary, EU, europe, European, export, extraction, Federal, finance, financing, German, Germany, government, growing, import, income, industry, international, invest, investing, investment, law, leadership, legal, legalization, legalize, legislation, leverage, license, Luxembourg, Malta, marijuana, market, medical, opportunities, product, Product Development, Quality, recreational, regulation, regulations, regulatory, retail, Soapbox, state, statement, Tilray, VC, venture

Investment Strategies for Entering the European Cannabis Market

For U.S. venture capitalists (VCs), the burgeoning European cannabis market provides opportunities to break into the industry on the heels of adult-use […]

January 20, 2022analysis, analytics, Aphria, business, Business Analysis, CANADA, canadian, cannabis, Cannin, Cannin Commentary, cbd, commentary, compliance, cultivation, Cultivation & Growing, Dispensaries & Retail, dispensary, earnings, EBITDA, EU, europe, European, export, extraction, Federal, finance, financial, German, government, growing, holdings, import, industry, investing, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, Operations, product, Product Development, Q2, Quality, quarter, recreational, regulation, regulations, regulatory, report, reporting, results, retail, revenue, second, state, thc, Tilray

Is Tilray Stock a Buy Post Fiscal Q2 Results?

Canadian cannabis giant Tilray (NASDAQ:TLRY) announced its fiscal second quarter of 2022 results last week. The company reported net revenue of $155 […]

April 29, 2021analysis, analytics, API, business, Business Analysis, CANADA, cannabis, compliance, cultivation, dispensary, England, EU, EU-GMP, europe, European, expansion, export, Federal, Germany, global, GMP, government, growing, Holland, import, industry, international, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, Netherlands, north america, Portugal, product, Quality, recreational, referendum, regulation, regulations, regulatory, retail, safety, spain, state, strict, test, thc, trade, U.K., U.N., United States, WHO

European Cannabis is Starting to Look Like the US Market 10 Years Ago

As the cannabis industry — now estimated to be worth more than USD 200 billion — continues to erupt around the world, […]

December 17, 20201, 19, 2020, 2021, 4, adult use, analysis, analytics, ballot, Biden, business, Business Analysis, CANADA, canadian, cannabis, cbd, commission, compliance, consumer, Coronavirus, court, COVID, COVID-19, cultivation, Denmark, deschedule, EC, economy, election, EU, Euro, europe, European, export, extraction, Federal, German, Germany, global, globe, government, growing, Holland, I, import, industry, initative, international, IV, law, legal, legalization, legalize, legislation, license, Luxembourg, marijuana, market, measure, medical, medicine, pandemic, policies, policy, Portugal, product, Quality, Recommendations, recreational, referendum, regulation, regulations, regulatory, reschedule, rescheduled, retail, safety, schedule, scheduling, spain, state, test, Testing, thc, UN, union, United Nations, vote, WHO, world, World Health Organization, worldwide

The 2020 Global Cannabis Regulatory Roundup

As a strange year heads to a final, painful finish, there have been some major (and some less so) changes afoot in […]

December 3, 20204, account, analysis, business, cannabis, classification, Commission for Narcotic Drugs, development, drug, EU, europe, European, export, Federal, global, government, growing, import, industry, international, law, legal, legalization, legalize, legislation, marijuana, market, medical, medicine, recommend, recommendation, recreational, regulation, regulations, regulatory, research, safety, Schedule IV, scheduling, state, The United Nations, Ukraine, UN, United States, USA, Vienna, vote, WHO, world, World Health Organization

UN Removes Cannabis From Schedule IV

The United Nations Commission for Narcotic Drugs, based in Vienna, Austria, voted to remove cannabis for medical use from its Schedule IV […]

December 1, 2020adult, adults use, analysis, analytics, business, CANADA, canadian, cannabis, cbd, compliance, cultivation, Danish, Denmark, dispensary, EU, europe, European, export, extraction, Federal, foreign, France, French, Germany, global, government, growing, Holland, import, industry, international, Israel, israeli, law, legal, legalization, legalize, legislation, license, Luxembourg, marijuana, market, medical, medicine, Netherlands, New Zealand, product, Quality, recreational, reform, regulation, regulations, regulatory, retail, safety, schedule I, state, test, thc, UK, UN, United Kingdom, United States, use, WHO, world, World Health Organization, worldwide

How Far Away Is Adult Use Cannabis Reform On The Global Calendar?

There is an ineffable logic to the pace of reform these days. Nowhere is that clearer in both the success of voter […]